SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-006568
Filing Date
2018-05-10
Accepted
2018-05-10 16:39:25
Documents
64
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 879401
2 ex31-1.htm EX-31.1 20692
3 ex31-2.htm EX-31.2 20751
4 ex32-1.htm EX-32.1 7914
5 ex32-2.htm EX-32.2 8185
  Complete submission text file 0001493152-18-006568.txt   3680210

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE crbp-20180331.xml EX-101.INS 441228
7 XBRL SCHEMA FILE crbp-20180331.xsd EX-101.SCH 46881
8 XBRL CALCULATION FILE crbp-20180331_cal.xml EX-101.CAL 51942
9 XBRL DEFINITION FILE crbp-20180331_def.xml EX-101.DEF 194140
10 XBRL LABEL FILE crbp-20180331_lab.xml EX-101.LAB 327512
11 XBRL PRESENTATION FILE crbp-20180331_pre.xml EX-101.PRE 266057
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 18823181
SIC: 2834 Pharmaceutical Preparations